Studies on the association between lipid profile and venous thromboembolism (VTE) are
inconsistent. This could be caused by classical lipoproteins being inferior to apolipoproteins …

Over the past decades, there have been great advances in the understanding of the
pathogenesis of venous thromboembolism (VTE) in patients with inherited and acquired …

The antiphospholipid syndrome (APS) refers to persistent antiphospholipid antibodies (aPL)
associated with thrombotic and/or obstetrical complications. The endothelial cell is a target …

Introduction The role of platelets (Ps) and platelet-derived microparticles (MPs) in venous
thromboembolism (VTE) is still being debated. Methods We measured MPs, velocity of …

The relationship between venous thromboembolism (VTE), dyslipidemia and lipid-lowering
drugs is complex and far from being completely elucidated [1, 2]. Lipid-lowering drugs are a …

Platelets exert fundamental roles in thrombosis, inflammation, and angiogenesis,
contributing to different pathologies from cardiovascular diseases to cancer. We previously …

Microparticles (MPs) are submicron vesicles released from the plasma membrane of
eukaryotic cells in response to activation or apoptosis. MPs are known to be involved in …

See also Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of
thrombotic risk? This issue, pp 146–7. Summary Background: Platelet size, measured as …

Essentials• The role of statins in hemostasis and venous thromboembolism (VTE)
prophylaxis is not clear.• This trial assessed whether rosuvastatin use affects thrombin …